Literature DB >> 33407366

Central hepatopancreatoduodenectomy-oncological effectiveness and parenchymal sparing option for diffusely spreading bile duct cancer: report of two cases.

Kapil Nagaraj1,2, Yuichi Goto3, Satoki Kojima1, Hisamune Sakai1, Toru Hisaka1, Yoshito Akagi1, Koji Okuda1.   

Abstract

BACKGROUND: Hepatopancreatoduodenectomy (HPD) for diffusely spreading bile duct cancer (DSBDC) usually involves a major hepatectomy and a concomitant pancreatoduodenectomy, and is still challenging surgery because of postoperative liver failure. The present case report demonstrated two cases of DSBDC where we could achieve successful HPD with central liver resection (CHPD) as liver parenchymal sparing surgery. CASE
PRESENTATION: In Case 1, endoscopic retrograde cholangiography (ERC) with multiple biopsies revealed that she had DSBDC with Bismuth-Corlette type IIIA. 3D integrated images reconstructed by contrast enhanced CT and CT with drip infusion cholecystocholangiography data revealed the right antero-ventral bile duct (RAVD) confluent to the right hepatic duct and the right antero-dorsal bile duct (RADD) independently confluent to the right posterior bile duct (RPD). Tumor extended common bile duct including intrapancreatic bile duct to the left hepatic duct and RAVD, but the RADD and RPD were spared. Because the future liver remnant (FLR) was assumed not to achieve desirable volume by preoperative portal vein embolization for left or right trisegmentectomy, CHPD including resection of the segments IV and I, and the right antero-ventral segment was done and achieved R0. This procedure is tailored to the anatomical extent of disease in the context of variable biliary anatomy as a modified CHPD, and to our knowledge, this is the first reported case of modified CHPD with antero-dorsal segment preservation. In Case 2, preoperative imaging revealed DSBDC with Bismuth Corlette type IIIA. FLR volume was assumed insufficient for major hepatectomy, CHPD including resection of the segments IV and I, and the right anterior sector was done with R0. The remnant liver volumes of these cases were spared by 55.1% and 25% respectively, and postoperative course was uneventful in both.
CONCLUSION: CHPD should be considered a valid option for well-selected cases of DSBDC. This is the first case report of modified CHPD with antero-dorsal segment preservation.

Entities:  

Keywords:  Case report; Central liver resection; Diffusely spreading bile duct cancer; Hepatopancreatoduodenectomy; Liver parenchymal sparing

Mesh:

Year:  2021        PMID: 33407366      PMCID: PMC7789542          DOI: 10.1186/s12893-020-01012-2

Source DB:  PubMed          Journal:  BMC Surg        ISSN: 1471-2482            Impact factor:   2.102


  24 in total

Review 1.  Left hepatectomy or left trisectionectomy with resection of the caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma (with video).

Authors:  Katsuhiko Uesaka
Journal:  J Hepatobiliary Pancreat Sci       Date:  2012-05       Impact factor: 7.027

2.  Anterior fissure of the right liver--the third door of the liver.

Authors:  Akihiro Cho; Shinichi Okazumi; Harufumi Makino; Fumihiko Miura; Kiyohiko Shuto; Ryouyu Mochiduki; Takayuki Tohma; Hidehiro Kudo; Katsuhiko Matsubara; Hisashi Gunji; Hiroshi Yamamoto; Munemasa Ryu; Takenori Ochiai
Journal:  J Hepatobiliary Pancreat Surg       Date:  2004

3.  Central hepatectomy with pancreatoduodenectomy for diffusely spread bile duct cancer.

Authors:  Takashi Mizuno; Hideyuki Kanemoto; Teiichi Sugiura; Yukiyasu Okamura; Katsuhiko Uesaka
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-12-08       Impact factor: 7.027

4.  Skeletization resection and central hepatic resection in the treatment of bile duct cancer.

Authors:  T T White
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

5.  High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry.

Authors:  Pim B Olthof; Robert J S Coelen; Jimme K Wiggers; Bas Groot Koerkamp; Massimo Malago; Roberto Hernandez-Alejandro; Stefan A Topp; Marco Vivarelli; Luca A Aldrighetti; Ricardo Robles Campos; Karl J Oldhafer; William R Jarnagin; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2017-03-06       Impact factor: 3.647

6.  Preoperative portal vein embolization: an audit of 84 patients.

Authors:  H Imamura; R Shimada; M Kubota; Y Matsuyama; A Nakayama; S Miyagawa; M Makuuchi; S Kawasaki
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

7.  Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project.

Authors:  Thuy B Tran; Monica M Dua; David A Spain; Brendan C Visser; Jeffrey A Norton; George A Poultsides
Journal:  HPB (Oxford)       Date:  2015-06-08       Impact factor: 3.647

8.  Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients.

Authors:  Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Yu Takahashi; Yuji Nimura; Masato Nagino
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

9.  Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.

Authors:  Masato Nagino; Junichi Kamiya; Hideki Nishio; Tomoki Ebata; Toshiyuki Arai; Yuji Nimura
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

Review 10.  Resection for Klatskin tumors: technical complexities and results.

Authors:  Ivan Capobianco; Jens Rolinger; Silvio Nadalin
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.